Lanadelumab | FDA Orange Book | Approved Drug Product List | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Lanadelumab
FDA Orange Book

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Contact Supplier

Jai Radhe Sales is your partner for all your sourcing needs.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Lanadelumab

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

DEVELOPMENTS

14 Drugs in Development

14 Drugs in Development

FINISHED DOSAGE FORMULATIONS

6 FDF Dossiers, 2 FDA Orange Book, 1 Europe, 2 Canada, 1 Australia

6 FDF Dossiers
2 FDA Orange Book
1 Europe
2 Canada
1 Australia

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 33 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
33 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 1 Finished Drug Prices, 5 Annual Reports

1 US Medicaid Prescriptions
1 Finished Drug Prices
5 Annual Reports

Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

2 All

01 2DYAX CORP.

filter Dosage Reset all filters

2 All

01 2SOLUTION;SUBCUTANEOUS

filter Regulatory Info Reset all filters

2 All

01 2Blank

filter Brand Name Reset all filters

2 All

01 2TAKHZYRO

filter RLD Reset all filters

2 All

01 2Blank

List of Suppliers

Product Main Page

01

DYAX CORP.

Fi Europe 2024

Not Confirmed

DYAX CORP.

Fi Europe 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD :

TE Code :

LANADELUMAB-FLYO

Brand Name : TAKHZYRO

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 300MG/2ML (150MG/ML)

Approval Date :

Application Number : 761090

RX/OTC/DISCN :

RLD :

TE Code :

Portfolio PDF

Product Web Link

Digital Content

02

DYAX CORP.

Fi Europe 2024

Not Confirmed

DYAX CORP.

Fi Europe 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD :

TE Code :

LANADELUMAB-FLYO

Brand Name : TAKHZYRO

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 300MG/2ML (150MG/ML)

Approval Date :

Application Number : 761090

RX/OTC/DISCN :

RLD :

TE Code :

Portfolio PDF

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?